CYP17A1 and prostate carcinoma: In addition, the authors thought that STARD3 and CYP17 expression in prostate cancer could lead to steroidogenesis through continuous cholesterol transfer into the mitochondria, increasing androgen biosynthesis via the catalytic activity of cytochrome CYP17.